Sep 14, 2015
Ayoxxa Biosystems said that Gerald Möller has joined its board as an independent director and as its chairman. He will guide the firm's expansion from life science research into disease-specific applications for Ayoxxa's Lunaris multiplexing technology. Möller has 40 years of management experience in the diagnostic and pharmaceutical industries and was most recently an investment advisor to HMB Partners. He held senior management positions at Boehringer Mannheim from 1975 to 1998 and became CEO of the worldwide operating group in 1995. He was also a board member at Illumina before leaving in May. He currently is chairman of Morphosys.